Carmat TAH Early Feasibility Study

Status Suspended

Clinical Trial Summary

Feasibility study of the Carmat TAH as a treatment for transplant-eligible patients in severe, end-stage heart failure.

Clinical Trial Description

This is a prospective, multi-center, staged feasibility study designed to assess the initial evidence of safety and performance of the Carmat TAH in the treatment of severe, end-stage heart failure. This study will include up to 7 centers in the US. The study population will include up to 10 transplant-eligible patients enrolled and implanted with the Carmat TAH. Data collection will be recorded prior to implantation of the device and for six months following implant, then long term at 9, 12, 18 and 24 months while the patient remains on the device. Adverse events, as defined by INTERMACS, while on device support will be collected throughout the study until study closure and will be adjudicated by an independent Clinical Event Committee. Progress reports of the clinical outcomes will be reviewed by the DSMB after implantation of each patient and every three months thereafter while any patient is supported with the device. A progress report will be sent to FDA for review after three subjects have been implanted and followed for 60 days. The primary objective of the study is survival on an original Carmat device at 180 days post-implant or survival to cardiac transplantation if occurring before 180 days post-implant. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04117295
Study type	Interventional
Source	Carmat SA
Contact
Status	Suspended
Phase	N/A
Start date	July 12, 2021
Completion date	January 2026

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06063811` - Ventricular Tachycardia Ablation in LVAD Patients
Withdrawn	`NCT04782245` - Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List	Phase 2
Active, not recruiting	`NCT04351945` - Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors
Recruiting	`NCT03966313` - Perioperative Modification of Hemostasis During Ventricular Assist Device Implantation
Recruiting	`NCT02592499` - Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure	N/A
Active, not recruiting	`NCT00490321` - VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy	Phase 3
Active, not recruiting	`NCT00483197` - VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal Trial	Phase 3
Completed	`NCT04543747` - Mechanical Circulatory Support Korea Post Market Surveillance Study (PMS)
Recruiting	`NCT04293575` - Transcatheter Mitral Valve Repair as Bridge Therapy to Heart Transplantation
Recruiting	`NCT04641416` - Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps
Completed	`NCT00490347` - VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial	Phase 2
Completed	`NCT05353816` - Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial	N/A
Completed	`NCT04480151` - ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)
Recruiting	`NCT04205760` - Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device	Phase 3
Recruiting	`NCT06345521` - The Follow-up System of Pediatric Heart Failure and the Establishment of End-stage Heart Failure Registry
Recruiting	`NCT04768322` - LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients	N/A
Completed	`NCT02248974` - Development & Testing of a Decision Aid for LVAD Placement	N/A
Completed	`NCT06152562` - Evaluation of Platelet Therapy Response in Left Ventricular Assist Device Patients
Completed	`NCT05928273` - Corheart 6 LVAS LTFU	N/A
Recruiting	`NCT04951999` - AssocIation of PULSatility and Occurrence of Complications Related to Mechanically Assisted Circulatory Support	N/A